145 related articles for article (PubMed ID: 30339968)
1. Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma.
Xie C; Liao H; Zhang C; Zhang S
Hum Pathol; 2019 Feb; 84():213-220. PubMed ID: 30339968
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP
Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
7. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.
Li PD; Zhang WJ; Zhang MY; Yuan LJ; Cha YL; Ying XF; Wu G; Wang HY
Med Oncol; 2012 Dec; 29(5):3070-6. PubMed ID: 22684641
[TBL] [Abstract][Full Text] [Related]
10. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
11. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
Zhao R; Li L; Yang J; Niu Q; Wang H; Qin X; Zhu N; Shi A
Pathol Oncol Res; 2020 Apr; 26(2):853-860. PubMed ID: 30852741
[TBL] [Abstract][Full Text] [Related]
14. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
[TBL] [Abstract][Full Text] [Related]
16. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
18. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
20. High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma.
Zhang X; Liu J; Yan S; Huang K; Bai Y; Zheng S
Int J Clin Exp Pathol; 2015; 8(11):14765-71. PubMed ID: 26823802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
